Clinical Trials Sponsored by MICALIS Institute

Total 74678 results

Hospital Universitari Vall d'Hebron Research Institute
Instituto de Salud Carlos III

Unknown

Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy (BETA)

Hepatic Encephalopathy | Cirrhosis

Spain
National Cancer Institute (NCI)

Completed

Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

Multiple Myeloma

United States
National Cancer Institute (NCI)

Terminated

p53 Vaccine for Ovarian Cancer

Ovarian Neoplasm

United States
National Eye Institute (NEI)

Completed

Color Vision as a Measure for Inherited Retinal Diseases

Healthy Volunteer | Retinal Disease | Inherited Retinal Degeneration

United States
National Cancer Institute (NCI)

Terminated

PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment

Lymphoma | Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Renal Cell Carcinoma | Graft-Versus-Host Disease | Engraftment Syndrome

United States
National Cancer Institute (NCI)

Terminated

Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Melanoma | Skin Cancer

United States
National Cancer Institute (NCI)

Completed

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Cervical Cancer | Anal Cancer | Vaginal Cancer | Oropharyngeal Cancer | Penile Cancer

United States
National Cancer Institute (NCI)

Completed

BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer

Metastatic Colorectal Cancer

United States
National Cancer Institute (NCI)

Completed

Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

T-Cell Project: Epidemiologic Component

Peripheral T-Cell Lymphoma

United States
National Eye Institute (NEI)

Completed

Infliximab to Treat Non-Infectious Scleritis

Scleritis

United States
National Cancer Institute (NCI)

Completed

A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression

Cancer | Spine Metastasis

United States
National Eye Institute (NEI)

Completed

Evaluation and Treatment of Patients With Inherited Eye Diseases

Hereditary Eye Disease

United States
National Eye Institute (NEI)

Completed

Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia

Aniridia

United States
National Eye Institute (NEI)

Completed

Evaluation and Treatment of Eye Complications of Vaccinia Vaccination

Vaccinia

United States
National Cancer Institute (NCI)

Withdrawn

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Sarcoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Completed

Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk

Risk Reduction Behavior | High Risk for Breast Cancer

United States
National Eye Institute (NEI)

Completed

Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires

Eye Disease

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma

Adenocarcinoma | Non-Small Cell Lung Cancer

United States
National Eye Institute (NEI)

Completed

Blood Factors and Diabetic Retinopathy

Diabetic Retinopathy

United States
National Eye Institute (NEI)

Completed

Screening for Research Subjects With Anterior Segment Diseases

Eye Diseases

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

Sarcoma | Lymphoma | Neuroblastoma | WilmsTumor

United States
National Cancer Institute (NCI)

Withdrawn

RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

Sarcoma | Lymphoma | Brain Neoplasms | Osteosarcoma | Wilm's Tumor

United States
National Eye Institute (NEI)

Completed

Genetic Study of Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
National Eye Institute (NEI)

Completed

Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema

Diabetic Retinopathy

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation

Cancer

United States
National Eye Institute (NEI)

Completed

Screening for Studies on Inherited Eye Diseases

Hereditary Eye Disease

United States
National Cancer Institute (NCI)

Completed

Natural History Study of Moles and Suspicious Melanoma

Melanocytic Nevi | Acquired Melanocytic Nevi | Primary Cutaneous Melanoma

United States
National Eye Institute (NEI)

Completed

Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa

Retinitis Pigmentosa

United States
National Eye Institute (NEI)

Completed

Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis

Uveitis

United States
National Eye Institute (NEI)

Completed

Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

Cancer | Mortality | Uveitis | Infection | Immunosuppression

United States
National Eye Institute (NEI)

Completed

Identification and Treatment of Feeder Vessels in Macular Degeneration

Macular Degeneration

United States
National Eye Institute (NEI)

Completed

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Von Hippel-Lindau Syndrome

United States
National Cancer Institute (NCI)

Completed

Specimens From Normal Controls

Viral Infections

United States
National Eye Institute (NEI)

Completed

Evaluation and Treatment of Patients With Retinal Disease

Retinal Disease

United States
National Eye Institute (NEI)

Completed

Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab

Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection

Blastomycosis

United States
National Eye Institute (NEI)

Completed

Dynamic Light Scattering to Study Crystalline Proteins in Young Normal Lenses

Healthy

United States
National Cancer Institute (NCI)

Completed

Late Effects of Treatment for Sarcomas in Children

Sarcoma

United States
National Cancer Institute (NCI)

Completed

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

Sarcoma

United States
National Cancer Institute (NCI)

Terminated

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Epithelial Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

Cutaneous T Cell Lymphoma | Peripheral T Cell Lymphoma

United States, Australia
National Cancer Institute (NCI)

Completed

Phase II ABT-888 With Cyclophosphamide

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Triple-Negative Breast Cancer | Serous Carcinoma Cancer

United States, Canada
National Cancer Institute (NCI)

Terminated

O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Brain and Central Nervous System Tumors

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Ponatinib for Advanced Medullary Thyroid Cancer

Thyroid Neoplasms

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Liver Cancer

United States
National Cancer Institute (NCI)

Completed

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Urothelial Carcinoma | Ureteral Neoplasms | Ureter Cancer | Cancer of the Ureter | Neoplasm, Ureteral

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Sarcoma | Kidney Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Melanoma (Skin)

United States

Clinical Trials Sponsored by MICALIS Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations